Andrew L. Guggenhime
2018
In 2018, Andrew L. Guggenhime earned a total compensation of $2.4M as Chief Financial Officer at Dermira, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,633 |
|---|---|
| Option Awards | $1,051,090 |
| Salary | $406,930 |
| Stock Awards | $747,375 |
| Total | $2,360,028 |
Guggenhime received $1.1M in option awards, accounting for 45% of the total pay in 2018.
Guggenhime also received $154.6K in non-equity incentive plan, $406.9K in salary and $747.4K in stock awards.
Rankings
In 2018, Andrew L. Guggenhime's compensation ranked 4,919th out of 14,244 executives tracked by ExecPay. In other words, Guggenhime earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,919 out of 14,244 | 66th |
Division Manufacturing | 1,847 out of 5,759 | 68th |
Major group Chemicals And Allied Products | 676 out of 2,122 | 68th |
Industry group Drugs | 566 out of 1,811 | 69th |
Industry Pharmaceutical Preparations | 435 out of 1,385 | 69th |
Pay ratio
| Andrew L. Guggenhime's Pay | $2,360,028 |
|---|---|
| Median Employee's Pay | $212,539 |
| Pay Ratio | 11to 1 |
In 2018, the annual total compensation of Andrew L. Guggenhime was $2,360,028.
The annual total compensation of the median employee at Dermira was $212,539.
The ratio of Andrew L. Guggenhime's pay to the pay of median employee was therefore 11 to one.
Source: SEC filing on April 24, 2019.
Guggenhime's colleagues
We found four more compensation records of executives who worked with Andrew L. Guggenhime at Dermira in 2018.